The incidence of avoidable or unavoidable, cardial and extracardial side effects is a risk in the drug treatment of supraventricular and ventricular tachyarrhythmias. Therefore the indication of antiarrhythmic drug therapy has to be considered critically. The patient has to be controlled close-meshed, especially at the beginning of the drug treatment. In patients with life threatening ventricular tachyarrhythmias, which can not be suppressed by drug therapy, nonpharmacological therapy--implantable cardioverter/defibrillator, catheterablation and heart-transplantation--has to be discussed.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
drug treatment
8
ventricular tachyarrhythmias
8
drug therapy
8
[therapy monitoring
4
monitoring cardiac
4
cardiac arrhythmias
4
arrhythmias guidelines
4
guidelines evaluation
4
evaluation anti-arrhythmia
4
anti-arrhythmia effects]
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!